By Sarah LaFave

/ Published March 30, 2020

The ongoing coronavirus pandemic has infected nearly three quarters of a million people worldwide, with more than 140,000 cases in the United States. As laboratories around the world—and here at Johns Hopkins—rush to develop treatments and vaccines for COVID-19, urgent questions remain about why some groups of people are more susceptible to severe illness compared to others and whether, as with other forms of coronaviruses, COVID-19 infections will taper off as the warmer months approach.

For answers to these questions, Sarah LaFave, PhD student at the Johns Hopkins School of Nursing, turned to Andrew Pekosz, a professor of molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health. He discussed what the latest

The post COVID-19: Immunity and seasonality – The Hub at Johns Hopkins appeared first on RocketNews | Top News Stories From Around the Globe.